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Abstract
Background: Although a few comparison methods based on the biological meaning of gene lists have been
developed, the goProfiles approach is one of the few that are being used for that purpose. It consists of projecting lists
of genes into predefined levels of the Gene Ontology, in such a way that a multinomial model can be used for
estimation and testing. Of particular interest is the fact that it may be used for proving equivalence (in the sense of
“enough similarity”) between two lists, instead of proving differences between them, which seems conceptually better
suited to the end goal of establishing similarity among gene lists. An equivalence method has been derived that uses
a distance–based approach and the confidence interval inclusion principle. Equivalence is declared if the upper limit
of a one-sided confidence interval for the distance between two profiles is below a pre-established equivalence limit.
Results: In this work, this method is extended to establish the equivalence of any number of gene lists. Additionally,
an algorithm to obtain the smallest equivalence limit that would allow equivalence between two or more lists to be
declared is presented. This algorithm is at the base of an iterative method of graphic visualization to represent the
most to least equivalent gene lists. These methods deal adequately with the problem of adjusting for multiple testing.
The applicability of these techniques is illustrated in two typical situations: (i) a collection of cancer-related gene lists,
suggesting which of them are more reasonable to combine –as claimed by the authors– and (ii) a collection of
pathogenesis–based transcript sets, showing which of these are more closely related. The methods developed are
available in the goProfiles Bioconductor package.
Conclusions: The method provides a simple yet powerful and statistically well-grounded way to classify a set of
genes or other feature lists by establishing their equivalence at a given equivalence threshold. The classification
results can be viewed using standard visualization methods. This may be applied to a variety of problems, from
deciding whether a series of datasets generating the lists can be combined to the simplification of groups of lists.
Keywords: Gene lists, Feature lists, Equivalence tests, Functional profiles
Background
Gene lists and gene list analysis
Omics technologies are characterized by the fact that the
analysis of the data generated often yields what is known
as “lists of genes” or, more generally, “lists of features”.
Features can be genes, proteins, microRNAs, etc., that
may have been selected for taking different values between
two or more conditions (that is, for being “differentially
expressed”) or for having good capability to discriminate
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between two or more classes, or to predict the class to
which a new individual belongs.
In a simplifiedway, one canusually consider “feature lists”
to represent a kind of summary of what is being analyzed.
It is important, however not to forget that this is not exempt
from criticism.
• First of all, these lists are often formed by multiple
elements associated with each main “feature”, i.e.,
several transcripts of a gene, several peptides of a
protein or multiple methylation sites of a gene. The
way in which multiple features collapse into a single
one in order to be summarized (the average, the most
variable, etc.) is not exempt from arbitrariness.
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• Secondly, and even more importantly, the lists are
usually obtained by applying a cut–off value with a
certain statistical basis (for example, an adjusted
p–value ≤ 0.05), which means that this list may
include (or exclude) genes that a reasonable change
in the selection criteria might exclude (or include).
Although much has been discussed about these issues,
and alternative approaches have been sought, the use of a
list as a summary of an experiment is still a very common
approach. This is not without foundation from a statis-
tical point of view, where it is generally assumed that a
summary may contain less information than all data.
Analysis of individual feature lists
The analysis of gene lists has a long history, probably
as long as the analysis of genomic data. Draghici [1]
introduced enrichment analysis or over–representation
analysis, which selects annotations that appear with a
surprisingly (unexpected) high frequency if we take into
account how they are distributed among all genes.Mootha
[2, 3] introduced the gene set enrichment analysis method
as an alternative to the analysis of cutoff–based lists. This
method analyzes all data (instead of the list) looking for
annotations that tend to appear in extreme cases (between
genes up- or downregulated) without requiring the list
to be cut by a point. Shojaie [4] went one step further
and performed the analysis of the lists based on the reg-
ulatory network implicitly associated with them. These
three methods are nothing more than the first of literally
dozens of variants of the same ones that have been devel-
oped in the last decade. Khatri [5] is an excellent review
of this process. Essentially all these methods share one
characteristic i.e. they are focused on the analysis of single
feature lists. Despite their relevance, which is why we are
mentioning them, their purpose is different from what is
discussed in this work: They do not seek to compare lists
but rather extract the biological information and therefore
will not be discussed here.
Comparison between two ormore feature lists
Comparison between lists has a shorter history because,
curiously, it is a topic that has attracted less attention than
the analysis of individual lists. This is probably for the
same reasons that there has been a tendency to perform
individual studies rather than to compare or group them:
the cost of studies, especially in their initial stage and often
their low reproducibility. In addition, many methods or
tools for comparing gene lists are based on a well–defined
statistical model, which also suggests that this has been
a relatively marginal issue. In general, we can differenti-
ate between: (i) methods that compare the composition of
the lists, either simply by the identifiers that form them
or by the ranges of those in the list; and (ii) methods that
project the elements in some other space such as the Gene
Ontology or provide other representations of the list such
as co–expression networks.
Among the first approaches, we find programs such
as GeneVenn [6], BioVenn [7] and VennPainters [8] that
perform a visual comparison based on more or less flex-
ible forms of Venn diagrams and are therefore limited
in terms of the number of lists that may be compared.
There are also applications such as CORal [9], Rank–Rank
Hypergeometric Overlap [10] and OrderedLists [11] that
are based on determining the degree of overlap of two or
more ordered lists. One characteristic of all these meth-
ods is that if they perform the comparison visually or by
using a statistical model, they do not refer to the biological
meaning of the list elements.
In this work, we are interested in methods that, in some
way, rely on the biological information in the lists. This
is usually done by basing the comparison on the anno-
tations of the genes in biological knowledge databases,
such as the Gene Ontology [12, 13]. There are several dis-
tinct approaches to doing this. Some programs start by
conducting an overrepresentation (or gene enrichment)
analysis of each list and then the set of enriched GO
terms obtained from each list is compared. This is the
case, for instance, with the PANTHER web tool [14]. The
clusterProfiler Bioconductor package [15] can also
be used in a very flexible manner, enabling comparison of
two or more gene lists based on the corresponding GO
or KEGG enriched terms. A different approach is to rely
on semantic similarity measures [16], which are used to
compare GO terms or entities annotated with GO terms
(in this case gene lists), by leveraging on the ontology
structure and properties. The GOSemSim Bioconductor
package [17] enables computation of a variety of such
measures, which may be used to compare gene lists. Last,
the method extended in this paper was introduced in
[18, 19] with the aim of providing an inferential basis for
comparing two gene lists. It is based on the annotations of
the lists at a fixed level of the Gene Ontology. The method
is implemented in the goProfiles package [20] also
available from Bioconductor.
Comparison betweenmultiple lists
As omics studies have becomemore complex, we are faced
with the need and the opportunity to work with several, or
even many, gene lists. We may have distinct scenarios for
this. For example:
• Sometimes researchers want to obtain “as much as
possible” from their expensive omics experiments
and compare everything vs everything even if some
comparisons are not relevant. This may result in
dozens of gene lists, which may contain redundant
information.
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• Sometimes researchers collect gene lists from
different studies because they consider these to be
about the same biological problem. This is the case
with the examples that will be discussed later in the
paper:
– Cancer-related gene lists (http://www.
bushmanlab.org/links/genelists, [21])
– Pathogenesis-based transcript sets
(https://www.ualberta.ca/medicine/institutes-
centresgroups/atagc/research/gene-lists, [22])
• The Molecular Signature Database (MsigDB, [23])
contains thousands of gene lists that might benefit
from some type of dimension reduction.
One may want to work on these lists for different pur-
poses which we may classify simplistically as dimension
reduction or dimension augmentation.
(i) Dimension reduction here would mean trying to
reduce the number of lists: for instance, referring to
the previous example, having a smaller number of
relevant signatures, or simplifying the exploration of
lists that result from some omics experiments.
(ii) Dimension augmentation, on the other hand, may
mean the possibility of combining datasets associ-
ated with gene lists derived from them. In other
words, if one can establish that a few lists are equiv-
alent, one may assume that the data that have gen-
erated them can also be considered equivalent, or,
which is the same thing, can be combined into a
single bigger dataset.
In recent years there have appeared several programs
intended to allow the comparison of more than two
lists. listcompare is a web tool that checks over-
lap of multiple gene lists (http://www.molbiotools.com/
listcompare.html) without making any use of biolog-
ical information contained in the lists. Other tools,
such as clusterProfiler [15] or ToppCluster
[24], perform a comparison based on doing an enrich-
ment analysis of each gene list and then relying on the
enriched categories to compare the lists. This compar-
ison is made either descriptively (clusterProfiler)
or interactively building a network with the enriched
terms (ToppCluster). The former tools, especially
clusterProfiler, have the merit that their compar-
ison provides hints on the biological difference between
the lists because they are based on enriched GO cate-
gories. A drawback, however, is the fact that these com-
parisons are visual only, with no inferential basis behind
them. The method presented in this paper does not
directly highlight the categories explaining the differences
between the lists but does provide an inferential basis for
the comparison, somehow complementing the others.
Difference vs equivalence hypotheses tests
A common misconception among practitioners of statis-
tics is to take up the fact of not rejecting a null hypothesis
as a proof of its veracity. The phrase “to accept the
null hypothesis”, though very common, is a statistical
nonsense. If anything (to some extent) is proven in an
hypotheses test, it is the alternative hypothesis when the
null hypothesis is rejected, but no inferences can be drawn
from not rejecting it. Posterior power arguments, say that
to try to infer the veracity of a nonrejected null hypothe-
sis from arguments of its (high) power computed from the
parameter estimates may lead to paradoxes [25]. Thus,
if the objective of an study is to prove similarity, e.g. to
decide if the biological information provided by two gene
lists is similar (but not necessarily exactly equal), from an
hypotheses testing perspective the right approach would
be to contrast a null hypothesis of relevant dissimilarity
against an alternative of irrelevant dissimilarity (not nec-
essarily null dissimilarity, i.e., exact equality, which may
lead to an undemonstrable statement). In practice, this
may be implemented by choosing a measure of dissimilar-
ity and establishing a threshold  of “acceptable” dissim-
ilarity. Then, the null hypothesis should specify that the
true measure of dissimilarity is not less than while, con-
versely, the alternative should specify that the dissimilarity
is less than .
Objectives
In this paper we present a statistical approach that allows
for: (i) given a predetermined equivalence threshold ,
to check the biological equivalence of the set of lists; and
(ii) for a set of given lists, to determine the minimum
equivalence threshold that allows the equivalence of the
set to be declared. With this approach, the efficiency of
the statistical tests is evaluated in a simulation study and
a graphic representation is provided to facilitate the inter-
pretation of the results. The application is illustrated using
two publicly available sets of gene lists (Kidney Gene Lists
and Cancer Gene Lists). The goProfiles Bioconductor
package has been extended to include the new capabilities
of the method.
Results
Previous work: statistical inference for functional profiles
The methods proposed in this work rely on biological
knowledge to compare two or more gene lists. In practice,
this means that biological annotations are used to charac-
terize each list in such a way that a method for comparing
these characterizations can be used. The method, known
as goProfiles, has been introduced elsewhere ([18, 19]) and
is reviewed briefly below.
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Given a list of n features annotated in theGeneOntology
(GO), a reasonable way to characterize this list is to count
how many features are annotated in each category (see
Figure 2 in [18]). This yields a frequency table that we call
functional profile describing how these n features are dis-
tributed between C1,C2, . . . ,Cs GO categories. However,
given that a feature can be annotated inmore than one cat-
egory, the frequencies obtained may add up to more than
n when counts are considered, or to more than 1 if we rely
on proportions. This complicates the analysis because,
for example, a chi–squared approach cannot be used to
model or compare these frequency tabulations. This was
solved in [18] by introducing the ideas of “expanded” and
“contracted” profiles. It is very common for a given feature
to be annotated in several categories. An expanded profile
allows multiple annotations to be transformed into sim-
ple ones so that each feature is annotated in one and only
one category. This is possible by defining this profile on
the Cartesian product partition C,C×C, . . . ,C × · · · × C
︸ ︷︷ ︸
s
excluding symmetric products. With this formulation, the
expanded profile is the vector of probabilities
P = (p1, . . . , ps, p11, ..., p(s−1)s, . . . , p123...s) (1)
where each pi1,i2,...,ik , k ≤ s, describes the probability
of simultaneous annotation in a possible combination of
categories so that a feature will always be annotated in
one and only one category of such expanded profiles.
Alternatively, the contracted profile, or simply profile for
short, is the vector of probabilities defined on the original
categories.
P = (p1., . . . , ps.) (2)
where pi. describes the probability of annotation in cate-
gory Ci, i = 1, ..., s. Expanded and contracted profiles are
related by a simple linear transformation (a “contraction”)
that turns an expanded into a contracted profile.
Given two lists of features of size n and m respectively,
the dissimilarity between their associated functional pro-
files P, Q can be evaluated by the squared Euclidean
distance (which in fact is not a true metric distance, just a
dissimilarity, as it does not verify the triangular inequality)
between them:
d (P, Q) =
s
∑
i=1
(pi· − qi·)2.
All quantities can be naturally estimated by their rela-
tive frequencies. Salicrú et al. [19] obtained the asymptotic
distribution of the estimated distance between two pro-
files and relied on this result to derive hypothesis tests for
comparing two feature lists.
( nm
n + m
)1/2
d(Pˆ−P, Qˆ−Q) d−→ Y ∼N (0, σPQ
) ≈ N
(
0, σPˆQˆ
)
,
(3)
where the “hat” notation stands for the sample pro-
files (the unknown probabilities substituted by the corre-
sponding relative frequencies) and the general expression
of σPQ is given in [19].
Besides classical comparison tests (to establish possible
“difference” against a null hypothesis of complete equal-
ity), equivalence tests (e.g. [26]) appear to be the natural
approach to testing when the goal is establishing (near)
equality. In accordance with the global distance-based
approach of the present paper, the problem can be stated
as follows:
Given two population profiles P andQ, instead of testing
H0 : d (P,Q) = 0 vs. H1 : d (P,Q) > 0, (4)
one aims to test:
H0 : d (P,Q) ≥  vs. H1 : d (P,Q) < , (5)
where “near equality” is stated in terms of a “practical
equivalence value”,  > 0.
Choosingthethreshold isadifficultquestion in equivalence
testing –and a subject commonly but wrongly ignored
in “differencetesting” (4), asa “statisticallysignificant” difference
(from zero) does not mean “biologically (clinically, etc.)
interesting” difference. In general, the chosen  value
should be an expert choice. But as can be seen below, the
method finally proposed in the present paper does not
depend on a given  choice.
The so-called “Interval Inclusion Rule” (e.g. as stated
in [27] under a distance-based approach) provides a gen-
eral way of solving equivalence testing problems. It can
be stated as follows (again adapted to the distance-based
approach):
(a) Obtain a 1 − α one-sided confidence interval [0, dU ]
for d (P,Q),
(b) Reject H0 in (5) if this confidence interval is fully
included in the parametric region of H1, say if
dU ≤ .
The above criterion defines a test with significance level α.
A consequence of (3) is that
dU = d
(
Pˆ, Qˆ
)
+ z1−α sˆedˆ (6)
is an asymptotically valid upper confidence level, where
sˆedˆ = σPˆQˆ
√
1
n + 1m stands for the estimated standard
error of d
(
Pˆ, Qˆ
)
and z1−α for the 1 − α quantile of a
standard Gaussian distribution, N(0, 1).
For convenience and in line with further developments
in this paper, the criterion to declare equivalence may be
restated in terms of p–values p() as:
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Declare equivalence if:
p() = (TPˆQˆ()) = P[Z ≤ TPˆQˆ()]≤ α, (7)
where  stands for the standard normal cumulative dis-
tribution function and
TPˆQˆ() =
d(Pˆ, Qˆ) − 
sˆePˆQˆ
. (8)
The above notation tries to highlight that both the
p–value and test statistic TPˆQˆ() depend on the cho-
sen equivalence limit, a crucial matter in the following
sections.
Equivalence test based on functional profiles for h ≥ 2
comparisons
Let L1, ..., Ls be s distinct lists, e.g. coming from s studies
on a similar subject. We wish to do a certain number, h ≤
s × (s − 1)/2, of previously specified comparisons (equiv-
alence tests) between these lists. For a given equivalence
threshold , this can be done by:
• first performing every selected comparison,
• and then doing a multiple testing adjustment in order
to deal with testing multiplicity.
There are many approaches to accounting for multi-
plicity. If the number of comparisons h is not big (e.g. at
most some tens, note that we are dealing with feature lists
comparisons, not with comparing the individual features
coming from a given study), a reasonable approach is to
control the “family wise error rate” (FWER), for instance,
using the Holm–Bonferroni criterion:
• Given an equivalence limit , compute the p–values
p1(), p2(), . . . , ph() associated with the test
statistics Tl() = Tij(), l = 1, 2, . . . , h;
i, j ∈ {1, . . . , s}.
• Sort the p–values in ascending order:
p(1) ≤ p(2) ≤ · · · ≤ p(h),
• The null hypothesis of non–equivalence (i.e. existence
of a “relevant” functional profile dissimilarity between
lists) is rejected for all those comparisons
l = 1, ..., k−1 such that pl() < pk()where k is the
smallest value satisfying that p(k)() > α/(h+1− k).
In the case of a great number h of comparisons, possibly
other criteria like the false discovery rate (FDR) for multi-
ple testing corrections would be the option to choose, but
the general idea is still the same.
Algorithm
As has been stated before, choosing the equivalence limit
may be a problematic task. But here we take what would
be a complementary approach: instead of previously fix-
ing , we will let it vary in order to give a numerical
value aiming to measure what would be a statistically
significant equivalence between lists, prone to graphical
representation and possible interpretation.
The first step is to build a dissimilarity matrix between
lists based on the threshold that makes them equivalent:
1. Set h = s × (s − 1)/2
2. Let h be the smallest value allowing the rejection of
all h null hypotheses, i.e. making k = h. Then one
has:
h= min
∈(0,∞)
{ : p(l)()≤α/(h+1−l), l=1, 2, . . . , h}.
3. Obtain h and take it as the threshold of equivalence
distance between lists i, j corresponding to the last
position in the vector of ordered p–values, i.e.
ij = h.
4. Set h = h − 1, exclude comparison between i and j
above and iterate step 2 until h = 0.
The resulting dissimilarity matrix may be the input for
an adequate representation method.
Visualization
Any data representation method accepting dissimilarity
matrices as a starting point can be applied using the ij
matrix. For example, it may be used to construct a den-
drogram showing the equivalence levels at which sets of
lists may be considered significantly equivalent. Although
many clustering methods may be used to build the den-
drogram, as a first approach, the “maximum distance”
or “complete linkage” method seems to be a reason-
able and useful choice. The maximum distance method
defines the distance between two groups as the distance
between their two farthest members. For a given set of
lists the construction of dendrograms using this method
is in accordance with the declaration of equivalence of the
most extreme lists, and consequently with the declaration
of equivalence of all pairs of lists.
Simulation study
An extensive simulation study was performed to investi-
gate the properties of the equivalence test. Several simula-
tion scenarios were created to cover a variety of situations
found in practice. These scenarios were considered: (i)
the number of common (n0) and distinct (n1 = n − n0,
m1 = m − n0) features in each list (ii) the number of GO
nodes on which the profiles are based and (iii) the dis-
tribution of annotations along the nodes in both profiles.
The simulated scenarios were generated crossing all levels
of the factors described above:
• (n,m) = (100, 100), (200, 200), (300, 100),
(300, 300), (400, 200), (1000, 1000), (1500, 500) and
n0 corresponding to 10%, 20% and 50% ofmin(n,m).
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• s = 10, 50, 100, where s corresponds to the number
of simulated GO nodes or items (in other words, the
length of the simulated basic profiles).
• θ = 0.55, 0.65, 0.75, 0.85, 0.95 and θ0 = 0.5.
•  = 0.025, 0.25, 1.25.
Each simulation consisted in repeatedly iterating the
following steps:
1. Independently generate three expanded profiles ̂P1,
̂Q1 and ̂R, from a multinomial distribution of sizes
n1,m1 and n0 and respective probability parameters:
P1 =
(
p1, p2, . . . , ps, p11, . . . , p(s−1)s, . . . , p1...k , . . . , p(s−(k−1))...(s−1)s
)
Q1 =
(
q1, q2, . . . , qs, q11, . . . , q(s−1)s, . . . , q1...k , . . . , q(s−(k−1))...(s−1)s
)
R = (r1, r2, . . . , rs, r11, . . . , r(s−1)s, . . . , r1...k , . . . , r(s−(k−1))...(s−1)s
)
.
Here, n1,m1 and n0 stand for the total number of
annotated genes in each generated expanded profile
and k stands for the allowed maximum number of
simultaneous annotation, k ≤ s, of the s annotated
GO items1. Remember that n1 stands for the genes
exclusively in the first list being compared,m1 for the
genes only in the second list and n0 for the genes
common to both lists, if any.
2. Build the finally compared profiles: ̂P = ̂P1 + ̂R and
̂Q = ̂Q1 + ̂R, with n = n1 + n0 andm = m1 + n0.
3. “Contract” ̂P and ̂Q to obtain the basic profiles Pˆ
and Qˆ.
4. Perform the equivalence test between these profiles
and collect all desired statistics (e.g., if equivalence
was declared or not in this single simulation
iteration).
For simplicity, in this section we will not continue using
the above notation for probability vectors like P1 (which
on the other hand is useful to highlight simultaneous
annotation of GO items) and we will simply designate
them as p1, . . . , pg , where g corresponds to the vector
length. In the simulations presented here, each one of
its components pi was obtained from a geometric model
dependent only on a single parameter 0 < θ < 1:
pi = θ(1 − θ)
i−1
1 − (1 − θ)g , i = 1, . . . , g.
Obviously, making the simulated profiles dependent on
a single parameter in this way greatly restricts the possi-
ble scenarios to be simulated. On the other hand, it allows
for an important simplification in order to trace the pro-
bability of declaring equivalence as a single function of the
simulated true squared Euclidean distance: given a value
of θ , P1 was obtained from θ ,Q1 was obtained from 1− θ
1For large values of s, e.g., s = 50 or more, it is advisable to take k < s to avoid
managing extremely large profile vectors
(say, qi = (1 − θ)θ i−1/(1 − θ g)) and R from a fixed θ0
value, independently of θ .
For fixed n,m, n0, θ0, s and k values, the squared
Euclidean distance is a function of θ , d = D(θ). Given a set
of desired d values (some less than , i.e. in a scenario of
false null hypothesis in the equivalence test; some greater
than , i.e. true null hypothesis; and one with d = ,
just on the limit of equivalence), numerically solving the
equation D(θ) = d we can obtain the required θ values
and thus a set of profiles to simulate these “population”
distances. Then simulations may be performed in order to
obtain the probability of rejecting the null hypothesis of
non–equivalence, i.e. to obtain the power curve of the test,
as a function of the d parameter.
Awell-behaved (unbiased) equivalence test should reject
the null hypothesis of nonequivalence with a probability
greater thanα forparametervaluesd < , with a probability
smaller than α for d >  and, ideally, with a proba-
bility of α when d = . Figures 1, 2 and 3 display the
probability of rejecting the null hypothesis of nonequiv-
alence (i.e., the probability of declaring equivalence) as a
function of the true simulated squared Euclidean distance.
They correspond to three sample sizes and the thresh-
old of equivalence scenarios. They show that the profiles
equivalence test is generally valid. As a consequence of
the Bonferroni-Holm method validity (as a way to protect
FWER), the equivalence test for more than two lists is
also generally valid. For very small equivalence limits (near
zero), there is some type I error inflation, with probabili-
ties slightly over the nominal significance level, e.g. values
around 0.06 for significance levels of 0.05. As supplementary
material (see Additional file 5) we provide three bar plots
representing the probabilities of false negatives and false
positives corresponding to Figs. 1, 2 and 3, respectively.
When the true simulated distance is d < , not reject-
ing the null hypothesis (not declaring equivalence) cor-
responds to a false negative. When d ≥ , declaring
equivalence is a false positive.
Software
The analysis of functional profiles, that is, the com-
putation of profiles and paired tests of difference or
equivalence has been implemented in the R package
goProfiles available in Bioconductor [20].
The current version of the package (1.44 or higher)
implements the capabilities described in this paper. That
is, given a set of gene lists –provided as Entrez
identifiers– one can: (i) compute a dissimilarity matrix
between the corresponding profiles at a given level of
any ontology; (ii) apply the algorithm described in the
previous section to determine the equivalence level at
which any pair of lists can be considered equivalent; and
(iii) visualize the associated dendrogram with the chosen
method.
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Fig. 1 Power curve of the equivalence test, as a function of the true squared Euclidean distance. Balanced case of two gene lists of size 200 with 20
genes in common. Equivalence limit at  = 0.25. The null hypothesis of the equivalence test states that the true squared Euclidean distance, d, is
greater than or equal to , that is to say, that both lists are sufficiently dissimilar according to the  limit criterion. Thus, rejecting this hypothesis
corresponds to declaring equivalence. When the true simulated distance is d < , not rejecting the null hypothesis not declaring equivalence )
corresponds to a false negative. When d ≥ , declaring equivalence is a false positive
The package is available in github (https://github.com/
alexsanchezpla/goProfiles) and in Bioconductor (http://
bioconductor.org/packages/goProfiles/).
Examples
We have selected two prototypical situations where we
believe that using the approach described in the paper
can be useful for simplifying the data the researchers are
working with, or even for shedding new light on their
meaning.
Equivalence analysis of kidney gene lists
Organ rejection diagnosis is mainly based on the study of
tissue biopsies (e.g. renal, lung, heart or liver) but, unfor-
tunately, the lesions observed using conventional histol-
ogy are often not specific for the underlying mechanism
since histological lesions (e.g., interstitial inflammation
in renal biopsies) maybe driven by different processes.
The molecular mechanisms operating in human organ
transplant rejection are best inferred from the mRNAs
expressed in biopsies because the corresponding pro-
teins often have low expression and short half–lives,
while small noncoding RNAs lack specificity. The study of
associations should be characterized in a population that
rigorously identifies the different mechanism participat-
ing in organ rejection, i.e. T cell–mediated and antibody–
mediated rejection (TCMR and ABMR). Associations can
be universal (both types of rejection), TCMR–selective, or
ABMR–selective. It has been proposed that top universal
transcripts are gamma–interferon–inducible and tran-
scripts shared by effector T cells and NK cells. TCMR–
selective transcripts are expressed in activated effector
T cells or gamma–interferon–inducedmacrophages while
ABMR–selective transcripts are expressed in NK cells
and endothelial cells. Transcript associations are highly
reproducible between biopsy sets when the same rejection
definitions, algorithm, and technology are applied, but
exact ranks will vary. Although rejection–associated tran-
scripts are never completely rejection–specific because
they are shared with the stereotyped response–to–
injury and innate immunity, transcriptomic analysis
using pathogenesis–based transcripts contributes to a
better characterization of mechanisms leading to organ
dysfunction.
This example uses a set of gene lists generically
described as “PBTs” (pathogenesis–based transcript
sets) studied by [22] and available at https://www.
ualberta.ca/medicine/institutes-centres-groups/atagc/
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Fig. 2 Power curve of the equivalence test, as a function of the true squared Euclidean distance. Balanced case of two gene lists of size 1,000 with
100 genes in common. Equivalence limit at  = 0.25. The null hypothesis of the equivalence test states that the true squared Euclidean distance, d,
is greater than or equal to , that is to say, that both lists are sufficiently dissimilar according to the  limit criterion. Thus, rejecting this hypothesis
corresponds to declaring equivalence. When the true simulated distance is d < , not rejecting the null hypothesis (not declaring equivalence)
corresponds to a false negative. When d ≥ , declaring equivalence is a false positive
research/gene-lists and as supplementary material2 (See
Additional file 1).
Each list consists of a series of probeset identifiers from
hgu133plus2 Affymetrix expression microarrays that
have been selected in distinct studies referenced in [22].
For this example the probesets have been preprocessed as
follows:
• Affymetrix identifiers have been converted into
Entrez identifiers using Biomart.
• When several probesets had the same identifier, this
appeared only once in the list.
This preprocessing yields five gene lists described in
Table 1 where, for each list, we provide its PBT abbrevia-
tion, the number of unique Entrez identifiers and a short
description.
Equivalence analysis of these gene lists can be easily
performed using functions in the goProfiles package
(see the detailed analysis example in Additional file 3). A
“standard” analysis has been performed that consists of
2Web pages may change and links become unavailable. To avoid these
problems the datasets used in the examples have been downloaded from their
public locations and added as supplementary materials
computing the dissimilarity matrix of equivalence thresh-
olds and building a dendrogram from this for the three
ontologies at levels from 2 to 8. These dendrograms can
be viewed in Fig. 4 (made at level 3 of the BP ontology) and
in Additional file 3 (levels 2 to 8 of all three ontologies).
As can be seen in the plots (Fig. 4 and supplementary
figures in Additional file 3) the grouping produced has the
same structure for all lists: kidney transcripts on one side
and endothelial and injury transcripts on the other, the lat-
ter being more similar to each other than to endothelial
transcripts. These groupings are not surprising because
each type of gene is involved in different biological pro-
cesses but they suggest that groupings observed in other
settings,wherethe relation between the lists is not obvious,
can also be considered as reasonable (see next example).
Equivalence analysis of cancer gene lists
As a second example, we consider a series of lists
that have been obtained from Bushman lab (http://
www.bushmanlab.org/links/genelists). The lists contain
Entrez identifiers for each gene so the only preprocess-
ing consisted of removing one list that contained less than
100 genes. Table 2 contains, for each list, the name, the
number of genes, the species and a short description.
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Fig. 3 Power curve of the equivalence test, as a function of the true squared Euclidean distance. Balanced case of two gene lists of size 200 with 20
genes in common. Equivalence limit at  = 0.025. The null hypothesis of the equivalence test states that the true squared Euclidean distance, d, is
greater than or equal to , that is to say, that both lists are sufficiently dissimilar according to the  limit criterion. Thus, rejecting this hypothesis
corresponds to declaring equivalence. When the true simulated distance is d < , not rejecting the null hypothesis (not declaring equivalence)
corresponds to a false negative. When d ≥ , declaring equivalence is a false positive
Citing the researcher’s description of the lists they are col-
lections of cancer-related genes that were used to generate a
comprehensive list (allOnco) that is comprised of the union
of all lists. In this case, we do not have any a priori expec-
tations of which lists should be equivalent to which but,
instead, we can rely on equivalence analysis to help answer
the question “up to what point can these lists be consid-
ered equivalent so that they can be merged into a single
list?”
Figure 5 and supplementary figures in Additional
file 4 show the results of equivalence analysis. Inter-
estingly the lists tend to group consistently within the
ontologies –groupings at distinct levels of the ontologies
are almost identical– but these groupings can change from
one ontology to another, which is not strange because
they refer to different concepts. Depending on what the
goal of merging the gene lists is the different groupings of
each ontology can be used as a guide to decide whether
a given dataset should be included or not in a common
list. For instance depending on whether what one wishes
to obtain is a heterogeneous or a homogeneous list one
could decide to include groups that are separated by a
higher threshold or, instead, that are near each other in the
dendrogram.
Table 1 Kidney gene lists
PBT Size PBT Name Biological Description
ENDAT 114 Endothelium-associated transcripts Microcirculation response to injury
IRITD3 313 Injury- and repair-induced transcripts day 3 Active injury–repair response: ’injury-up’ Increased in isografts peaking day 3
IRITD5 221 Injury- and repair-induced transcripts day 5 Active injury–repair response: ’injury-up’ Increased in isografts peaking day 5
KT1 574 Kidney transcripts—set 1 Active injury–repair response: ’injury-down’ Parenchymal transcripts
KT1.1 119 Kidney transcripts - Set 1.1 Humanized mouse kidney selective transcripts reduced >90% in day 21 mouse allografts
Pathogenesis-based transcript sets or “PBTs”. The lists have been selected from the datasets available in the file “PBTs_all_affy” downloaded from the url: https://www.
ualberta.ca/medicine/institutes-centres-groups/atagc/research/gene-lists. Only lists with more than 100 transcripts have been retained. Transcript names have been
converted from probeset identifiers into Entrez identifiers. Given that several probesets are associated to the same Entrez ID the final gene lists are usually shorter than
transcript lists. Since the file has been downloaded the web page has changed and this file is not available anymore, although new version of the file can be found in the site
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Fig. 4 Dendrogram produced from the equivalence analysis of kidney gene lists made at level 3 of the BP ontology. The lists are grouped naturally
depending on the type of process on which the genes of the lists are involved. See Additional file 3 for supplementary figures at levels 2 to 8 of all
three (MF, CC and BP) ontologies
Discussion and limitations
In this paper, a method for dealing with the problem of
simultaneously comparing multiple feature lists has been
introduced. The method is based on comparing feature
lists by means of their projections at fixed Gene Ontology
levels. These projections are called “functional profiles”.
One innovative characteristic is that the comparison is
done by means of equivalence tests, which are aimed
at rejecting a null hypothesis of nonequivalence, which
means that it can be stated (when this null hypothesis is
Table 2 Cancer Gene Lists
Set Size Species Description
Atlas 989 human Genes: hybrid gene found in at least one cancer case, or gene amplification or homozygous deletion found
in a significant subset of cases in a given cancer-type.
CANgenes 189 human 191 common genes that weremutated at significant frequency in all tumors of human breast and colorectal
cancers.
CIS (RTCGD) 587 multiple Retroviral insertional mutagenesis in mouse hematopoietic tumors.
Miscellaneous 187 multiple From Cold Spring Harbor Retroviruses Chapter on Oncogenes, an early version of the CIS database, a list
from Dr. Tony Hunter, and misc. additions from the literature.
Sanger 452 human Compilation from literature: “genes that are mutated and causally implicated in cancer development”
Vogelstein 420 human Cancer genes related to chromosomal breakpoints
Waldman 455 Human Gene set is from the Waldman gene database and lists cancer genes sorted by chromosomal locus and
includes links to OMIM.
Cancer related genes that were used to generate a comprehensive list (allOnco) that is comprised of the union of all lists The lists have been selected from the datasets
available in the file “allOnco.tsv” downloaded from the url http://www.bushmanlab.org/links/genelists. Only lists with more than 50 genes have been retained. Since the file
has been downloaded the web page has changed and this file is not available anymore, although new version of the file can be found in the site
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Fig. 5 Dendrogram produced from the equivalence analysis of cancer gene lists made at level 3 of the BP ontology. In this case there are no natural
groupings but instead, the dendrogrammay be used to suggest which lists may be combined more reasonably than others. See Additional file 4 for
supplementary figures at levels 2 to 8 of all three (MF, CC and BP) ontologies
rejected) thattwolistsare “equivalent at a certain threshold”.
This is a better statement than simply saying that “there
is no evidence of difference or dependency” (which does
not mean that they are equal or independent), as would be
the case if a “standard” difference or dependency test was
performed. The fact that it relies upon equivalence makes
it particularly interesting for data integration problems,
such as for the cancer gene lists presented in the examples.
Following a reviewer suggestion we compared the
equivalence test with a standard test of positive depen-
dency. Although appealing, this test is not adequate to
solve the proposed problem. Its limitations are shown in
the supplementary material (see Additional file 6).
The examples have shown that themethod behaves con-
sistently with expected similarities. That is, it tends to
consider equivalent at lower threshold feature lists that –
even if they have few elements in common – are expected
to be easily declared equivalent. One can interpret that
this happens because they are associated with the same
or similar biological processes, such as with injury-related
PBTs in the kidney gene lists examples. This, of course,
suggests that when two lists, whose relationship is not
known, show up as equivalent they can be considered
similar enough.
The method is not free from limitations. For instance
an obvious concern may be the fact that comparisons
are made separately at each level of each ontology, which
means, for instance, that if one considers three levels
(e.g. 2, 3 and 4) of the three ontologies (CC, BP and
MF) one ends up with nine comparisons that one may
want to combine a posteriori. In spite of its apparent
inconvenience, this may be seen as useful – firstly because
in general, a good consistency and reproducibility are
observed between different levels of the same ontology;
that is, they yield generally the same classification, and
small differences observed may be mostly attributable to
list size. In some cases, there may be differences between
ontologies, but this is not a serious drawback either,
because the distinct ontologies reflect distinct biological
concepts, so differences can be considered reasonable. If
all the comparisons were compacted into a single one
this variability might be lost, which could hamper the
interpretation of the results.
Another issue to be accounted for is computational
efficiency. This depends on many factors, such as the
computer where the programs are run, the number of
lists to compare, the size (number of features) of these
lists and the number of GO nodes in the profiles being
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compared. A small simulation study has been performed
to provide information about execution times in a realis-
tic scenario: using a basic bioinformatic station (i7-4790
processor with 8GB of RAM running R 3.4 on 64-bit
Windows 7 Enterprise) the process of determining the
equivalence of a certain number of random gene lists
has been executed repeatedly. This has been done using
the equivClust function of the current version (1.44.0)
of the goProfiles package. Times were measured by
means of the R package microbenchmark, which pro-
vides summary statistics for the running time. The num-
ber of lists compared in the simulations was 5, 10, 25 and
50. For simplicity pairs of lists being compared were set
to have the same size. The sizes considered were 100, 200,
1000, 2000 and 5000. The comparison was made at levels
2 and 3 of the “Biological Process” (BP) ontology.
Table 1 and Fig. 1 in Additional file 7 show the sum-
maries of the execution times in five replicates (if the
number of genes was 5000 only one replicate was used). It
can be seen that, at level 3, the required time to build an
equivalence dendrogram for 50 gene lists and 5000 genes
is more than 32 hours (115858.16/3600) which is clearly
not assumable for ordinary calculations.
Conclusions
The method introduced in this work provides a way for
classifying sets of genes or other features based on equiv-
alence testing on their corresponding functional profiles.
It can be viewed as an extension of the goProfiles
methodology [19, 20] introduced previously and it is sta-
tistically well grounded. Standard visualizations, such as
dendrograms, can be used to depict the classification
results. The method has a wide applicability and has been
used in a variety of problems such as deciding whether a
series of datasets generating the lists can be combined, or
in regard to classifying the lists in a collection of signatures
from most to least similar, in the sense of equivalence.
Additional files
Additional file 1: Comma separated file containg original data for the
Kidney lists example. Each list is a collection of affymetrix probesets from
hgu133plus2 arrays. The file was downloaded from the url: https://www.
ualberta.ca/medicine/institutes-centres-groups/atagc/research/gene-lists.
(TSV 61 kb)
Additional file 2: Comma separated file containg original data for the
Cancer lists example. Each list is a collection of Entrez identifiers from
human or from another species. The file was downloaded from the url:
http://www.bushmanlab.org/links/genelists. (CSV 284 kb)
Additional file 3: This file contains an extended version of the Kidney data
analysis example. Plots of the dendrograms produced up to the 8th level of
the GO are shown. Analysis of the data based on Semantic Similarity (SS)
are provided. Informal comparisons among results obtained using distinct
SS measures and with results obtained with goprofiles are presented.
Each plot is in a separate page to facilitate visualization. (PDF 214 kb)
Additional file 4: This file contains an extended version of the Cancer data
analysis example. Plots of the dendrograms produced up to the 8th level of
the GO are shown. Analysis of the data based on Semantic Similarity (SS)
are provided. Informal comparisons among results obtained using distinct
SS measures and with results obtained with goprofiles are presented.
Each plot is in a separate page to facilitate visualization. (PDF 187 kb)
Additional file 5: The simulation study performed shows the ROC curves
but a reviewer suggested that depicting False Positive and False Negative
rates could also be interesting. This file shows three plots with FN (in blue)
and FP (in red), as a function of some values of the true squared Euclidean
distance. The plots differ in the total number of genes and the number of
genes in common between the three lists. (PDF 30 kb)
Additional file 6: Comparison between the equivalence test with a
standard test of positive dependency suggested by a reviewer. (PDF 348 kb)
Additional file 7: Summary results from a small simulation study
performed to provide information about execution times in a realistic
scenario. (PDF 166 kb)
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